Skip to main content
. 2017 Nov 30;8(69):114371–114392. doi: 10.18632/oncotarget.22825

Figure 3. Somatic alterations of ERBB2 in cancer.

Figure 3

(A, B) Frequency of ERBB2 copy number amplifications (A) or putative driver mutations (B) in selected cBioPortal and GENIE datasets. (C) Distribution of somatic variants within ERBB2 across its domain-annotated protein structure in all cBioPortal studies. NSCLC, non-small cell lung cancer; GBM, glioblastoma multiform; MBC, metastatic breast cancer; GF Recep IV, Growth Factor Receptor IV domain.